secwatch.observer — SEC 8-K summary
======================================

Issuer:     KINETA, INC./DE (—)
CIK:        0001445283
Form:       8-K
Filed at:   2025-07-01T23:59:59+00:00
Accession:  0000950170-25-091820
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 2.01, 3.03, 5.01, 5.02, 5.03, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TuHURA Biosciences completes acquisition of Kineta; Kineta stockholders get 0.185298 HURA shares each
--------------------------------------------------------------------------------

- Each Kineta share converted into 0.185298 shares of TuHURA common stock; ~2.87M HURA shares issued at close.
- 2nd contingent consideration: 1,129,885 additional HURA shares issuable after 6 months, subject to loss adjustments.
- Kineta VISTA mAb (KVA12123, now TBS-2025) added; Phase 2 trial in NPM1-mutated AML planned for H2 2025.
- Fourth tranche of $12.5M PIPE financing unlocked upon closing.
- Kineta stock halted on OTC Pink; company will file Form 15 to terminate SEC registration. All directors/officers resigned.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1445283/000095017025091820/0000950170-25-091820-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1445283/000095017025091820/kant-20250630.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-091820

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer